Saturday 17 October 2026 Export CSCIF’s income statement to Excel — free account

COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc.’s revenue for fiscal 2025 (year ended December 2025) was $7.5 million, down 21.8% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS grew 92.6% and free cash flow grew 113.3%, each against the same quarter a year earlier.

6.49 0.24 +3.84%

Follow CSCIF

Alert me

Market cap: $8.6M
P/E: 1.0×
Fwd P/E: —
Dividend yield: —
F-score: 3/9
Altman Z: −2.08
Beneish M: −2.95
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	3	5	6
ROE Full definition →		(118.80%)	(121.84%)	31.84%	59.74%
ROA Full definition →		(44.08%)	(36.66%)	16.22%	28.24%
ROIC Full definition →		0.00%	0.00%	(51.58%)	(40.56%)
Return on Tangible Assets Full definition →		(75.50%)	(58.54%)	23.91%	40.44%
Average Days of Receivables Full definition →		68.05	61.39	90.99	99.19
Free Cash Flow per Share Full definition →		(10.36)	(8.47)	(8.23)	(3.36)
Free Cash Flow Full definition →		(10.97)	(8.93)	(8.61)	(3.52)
Capital Expenditures Full definition →		(0.96)	(0.46)	0.16	0.20
Other line items
Cash ROIC Full definition →		(80.61%)	(80.14%)	(42.38%)	(17.50%)
Accounts Receivable Turnover Full definition →		4.76	4.02	4.15	3.39
Accounts Payable Turnover Full definition →		1.42	1.47	1.75	2.42
Inventory Turnover Full definition →		1.90	2.43	2.77	3.36
Average Days of Payables Full definition →		147.61	141.68	68.59	62.60
Days of Inventory on Hand Full definition →		133.29	98.34	81.40	75.03
Tax Rate Full definition →		0.00	0.09	0.00	0.00
Research and Development Expense of Revenue Full definition →		50.75%	39.34%	32.87%	26.69%
Selling, General and Administrative Expense of Revenue Full definition →		111.43%	134.20%	110.99%	90.04%
Share Based Compensation of Revenue Full definition →		(1.05%)	(0.16%)	(0.21%)	0.78%
Interest Coverage Full definition →		(85.48)	(62.15)	(58.70)	(33.19)
Operating CF/Net income Full definition →		0.67	0.82	(2.16)	(0.57)
Depreciation/Fixed assets Full definition →		0.04	0.11	0.12	0.14
Capex/Depreciation Full definition →		(2.66)	(0.43)	0.14	0.16
Revenue per Share Full definition →		8.13	7.11	7.64	8.33
Operating CF per Share Full definition →		(9.45)	(8.03)	(8.38)	(3.56)
Capex per Share Full definition →		(0.91)	(0.44)	0.15	0.19
Capex to Sales Full definition →		0.11	0.06	(0.02)	(0.02)

Show all line items

Columns are period end dates

Stockrow Weekly